Dual-Filter Sensing in Implantable Defibrillators to Reduce T-Wave Oversensing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Non-vascular implantable cardioverter defibrillators (NV-ICDs) face challenges in accurately filtering cardiac electrical signals, leading to T-wave oversensing and arrhythmia undersensing due to inappropriate signal filtering, which can result in inappropriate therapy delivery.
Innovation Solution
Implementing a dual bandpass filter system with automatic switching between filters to optimize R-wave detection, using a first filter with a narrower frequency range and a second filter with a wider frequency range to minimize both T-wave oversensing and R-wave undersensing, thereby reducing false detections of ventricular tachycardia (VT) and ventricular fibrillation (VF).
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If a narrow bandpass filter is used to reduce T-wave oversensing, then T-wave detection accuracy improves, but R-wave detection sensitivity deteriorates
Solution Approach 1:
The system dynamically switches between two different bandpass filters (narrow and wide) based on the detected cardiac rhythm state. During sinus rhythm, the narrow filter is used to reduce T-wave oversensing. During arrhythmia detection, the wide filter is used to ensure R-wave detection sensitivity. This dynamic adaptation resolves the contradiction by allowing each filter to operate in its optimal condition for the specific cardiac state.
Solution Approach 2:
The system changes the frequency parameters of the bandpass filter by selecting between two pre-configured filter settings. The narrow filter has a higher lower-cutoff frequency to attenuate T-waves, while the wide filter has a lower lower-cutoff frequency to capture R-waves during arrhythmia. This parameter switching allows the system to optimize detection accuracy for different cardiac conditions.
2Reliability
If a wide bandpass filter is used to improve R-wave detection sensitivity, then arrhythmia detection reliability improves, but T-wave oversensing increases
Solution Approach 1:
The system dynamically selects the appropriate filter width based on the current cardiac rhythm. During sinus rhythm when T-waves are prominent, the narrow filter is activated to minimize T-wave oversensing. During arrhythmia detection when R-wave sensitivity is critical, the wide filter is activated to ensure reliable detection. This dynamic selection prevents T-wave oversensing while maintaining arrhythmia detection reliability.
Solution Approach 2:
The filtering function is segmented into two distinct filter configurations, each optimized for specific cardiac conditions. The narrow filter handles sinus rhythm detection by blocking T-waves, while the wide filter handles arrhythmia detection by capturing all relevant signals. This segmentation allows the system to avoid T-wave oversensing in normal conditions while maintaining sensitivity during arrhythmia.
3Measurement precision
If signal filtering is applied to remove noise, then signal quality improves, but false detections of ventricular tachycardia and ventricular fibrillation increase
Solution Approach 1:
The system dynamically adjusts the filtering aggressiveness based on the detected rhythm state. During sinus rhythm, the narrow filter provides aggressive noise filtering while the controller recognizes normal T-waves and avoids false arrhythmia diagnoses. During arrhythmia detection, the wide filter is used with arrhythmia detection algorithms that are specifically tuned to recognize VT/VF patterns, reducing false detections caused by inappropriate filtering.
Solution Approach 2:
The controller uses feedback from the detected signal characteristics to determine whether to switch between filter modes and to interpret detected events appropriately. When the narrow filter is active, the controller expects to see T-waves and adjusts its interpretation accordingly to avoid false arrhythmia diagnoses. When the wide filter is active during suspected arrhythmia, the controller uses arrhythmia-specific detection criteria to confirm true positives and reject false positives.
Data Source
AI summary
Described herein are implantable medical devices and systems, and methods for use therewith, for reducing T-wave oversensing and arrhythmia undersensing that occur due to inappropriate filtering of a signal indicative of cardiac electrical activity. A method includes obtaining a signal indicative of cardiac electrical activity, and using a first bandpass filter to produce a first filtered version thereof, using a second bandpass filter to produce a second filtered version thereof, wherein the first bandpass filter passes frequencies within a first frequency range, and the second bandpass filter passes frequencies within a second frequency range that is wider than the first frequency range. The method also includes selectively changing from using the first filtered version of the signal to monitor for a VS event, to using the second filtered version of the signal to monitor for a VS event, based on first criteria, and vice versa, based on second criteria.